137 related articles for article (PubMed ID: 14603610)
1. [Acute exacerbated chronic bronchitis. Antibiotics in comparison].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603610
[No Abstract] [Full Text] [Related]
2. [The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis].
Villalobos PA; Valle DD
Arch Soc Esp Oftalmol; 2010 Oct; 85(10):323-4. PubMed ID: 21168055
[No Abstract] [Full Text] [Related]
3. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
4. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
5. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Niederman MS; Anzueto A; Sethi S; Choudhri S; Kureishi A; Haverstock D; Perroncel R
Respir Med; 2006 Oct; 100(10):1781-90. PubMed ID: 16531032
[TBL] [Abstract][Full Text] [Related]
6. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
[TBL] [Abstract][Full Text] [Related]
8. No more equivalence trials for antibiotics in exacerbations of COPD, please.
Miravitlles M; Torres A
Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
[No Abstract] [Full Text] [Related]
9. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Iudina LV; Snezhko VI; Rachko IuV
Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin--a new fluoroquinolone antibacterial.
Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
[TBL] [Abstract][Full Text] [Related]
11. Intravenous moxifloxacin. Even more harmful than the oral form.
Prescrire Int; 2011 Jun; 20(117):151. PubMed ID: 21678703
[No Abstract] [Full Text] [Related]
12. Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only.
Koh WJ; Jeon K; Shin SJ
Antimicrob Agents Chemother; 2013 Feb; 57(2):1098-100. PubMed ID: 23183432
[No Abstract] [Full Text] [Related]
13. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Martin M; Moore L; Quilici S; Decramer M; Simoens S
Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
[TBL] [Abstract][Full Text] [Related]
14. [Moxifloxacin (Kanavig), ophthalmic administration].
J Pharm Belg; 2012 Jun; (2):41-2. PubMed ID: 22978015
[No Abstract] [Full Text] [Related]
15. Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin.
Bishai WR
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):405-16. PubMed ID: 16771618
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
18. 10 years' experience with the pneumococcal quinolone moxifloxacin.
Burkhardt O; Welte T
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):645-68. PubMed ID: 19681692
[TBL] [Abstract][Full Text] [Related]
19. [Acute exacerbated bronchitis. New guidelines for choice of antibiotics].
MMW Fortschr Med; 2001 Nov; 143(48):59. PubMed ID: 11770382
[No Abstract] [Full Text] [Related]
20. [After stroke threatens pneumonia. Antibiotics to be given prophylactically?].
MMW Fortschr Med; 2004 Oct; 146(44):15. PubMed ID: 15566241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
